Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study

Published:2013-04 Issue:4 Volume:24 Page:986-992
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kreuter M.,Vansteenkiste J.,Fischer J.R.,Eberhardt W.,Zabeck H.,Kollmeier J.,Serke M.,Frickhofen N.,Reck M.,Engel-Riedel W.,Neumann S.,Thomeer M.,Schumann C.,De Leyn P.,Graeter T.,Stamatis G.,Zuna I.,Griesinger F.,Thomas M.

Funder

Eli Lilly and Company

Medac GmbH, Wedel

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/4/986/720495/mds578.pdf

Reference38 articles.

1. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report;Fry;Cancer,1999

2. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

3. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

4. Chemotherapy for patients with non-small cell lung cancer. The surgical setting of the Big Lung Trial;Waller;Eur J Cardiothorac Surg,2004

5. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancements in Minimally Invasive Surgery for Early Stage Non-Small Cell Lung Cancer: A Narrative Review;Journal of Clinical Medicine;2024-06-06

2. A novel model to predict the risk of hematological toxicity in lung adenocarcinoma patients with pemetrexed plus platinum chemotherapy based on real-world data;Current Problems in Cancer;2024-02

3. Prognostic Significance of Tumor Mutation Burden among Patients with Non-small Cell Lung Cancer Who Received Platinum-based Adjuvant Chemotherapy: An Exploratory Study;Journal of Cancer Prevention;2023-12-30

4. The role of immunotherapy in neoadjuvant treatment of non-small cell lung cancer—a narrative review;AME Surgical Journal;2023-10

5. Expanding the usage of osimertinib as adjuvant therapy for <i>EGFR</i>-mutated NSCLC: a model-based assessment of its impact on reducing cancer mortality in Russia;Meditsinskiy sovet = Medical Council;2023-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3